Organovo Holdings Inc logo

Organovo Holdings Inc

$ 2.14 +0.06 (+2.88%) 08:08 PM EST
P/E:
At Loss
P/B:
0.68
Market Cap:
$ 18.64M
Enterprise V:
$ -5.98M
Volume:
19.05K
Avg Vol (2M):
110.40K
Also Trade In:
Volume:
19.05K
Market Cap $:
18.64M
PE Ratio:
At Loss
Avg Vol (2-Month):
110.40K
Enterprise Value $:
-5.98M
PB Ratio:
0.68
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels.
Name Current Vs Industry Vs History
Cash-To-Debt 12.52
Equity-to-Asset 0.91
Debt-to-Equity 0.08
Debt-to-EBITDA -0.17
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -10.75
Distress
Grey
Safe
Beneish M-Score 0.92
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 52.94
9-Day RSI 43.07
14-Day RSI 41.23
6-1 Month Momentum % -34.04
12-1 Month Momentum % -62.74

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 20.99
Quick Ratio 20.99
Cash Ratio 20.43

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12

Financials (Next Earnings Date:2022-11-08 Est.)

ONVO's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ONVO

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1.5
EPS (TTM) ($) -1.392
Beta 0.9
Volatility % 90.27
14-Day RSI 41.23
14-Day ATR ($) 0.191881
20-Day SMA ($) 2.26125
12-1 Month Momentum % -62.74
52-Week Range ($) 1.71 - 6.9675
Shares Outstanding (Mil) 8.71

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Organovo Holdings Inc Filings

Document Form Filing Date
No Filing Data

Organovo Holdings Inc Analysis

Share your research

Headlines

See More
No news.